What is Emtricitabine-Rilpivirine-and-Tenofovir-Alafenamide: Uses, Dosage, Side Effects and More

Emtricitabine-rilpivirine-and-tenofovir-alafenamide is a combination medication used to treat HIV infection in adults and adolescents. This single pill contains three different HIV medicines that work together to help control the virus in your body.

You might know this medication by its brand name Odefsey. It's designed to make HIV treatment simpler by combining three effective medicines into one daily tablet, which can help you stick to your treatment plan more easily.

What is Emtricitabine-Rilpivirine-and-Tenofovir-Alafenamide?

This medication is a complete HIV treatment regimen in a single pill. It combines three different types of HIV medicines that attack the virus in different ways to prevent it from multiplying in your body.

The three components work as a team. Emtricitabine and tenofovir alafenamide are both nucleoside reverse transcriptase inhibitors, while rilpivirine is a non-nucleoside reverse transcriptase inhibitor. Think of them as blocking different pathways the HIV virus needs to reproduce.

This combination is considered a complete treatment regimen, meaning you don't need to take additional HIV medicines with it. Your doctor will prescribe this if it's the right fit for your specific situation and viral load.

What is Emtricitabine-Rilpivirine-and-Tenofovir-Alafenamide Used For?

This medication is specifically used to treat HIV-1 infection in adults and adolescents who weigh at least 35 kilograms (about 77 pounds). It's designed for people who are either starting HIV treatment for the first time or switching from another HIV regimen.

Your doctor will typically prescribe this if your viral load is below 100,000 copies per milliliter of blood. This threshold is important because rilpivirine, one of the components, works best when the viral load isn't extremely high.

It's also used for people who want to simplify their HIV treatment. If you're currently taking multiple HIV pills throughout the day, your doctor might switch you to this once-daily option to make your routine easier to manage.

How Does Emtricitabine-Rilpivirine-and-Tenofovir-Alafenamide Work?

This medication works by blocking HIV from making copies of itself in your body. Each component targets a different step in the virus's reproduction process, creating multiple barriers that HIV can't easily overcome.

Emtricitabine and tenofovir alafenamide work by mimicking the building blocks that HIV needs to create its genetic material. When the virus tries to use these fake building blocks, it can't complete the copying process and gets stuck.

Rilpivirine works differently by directly blocking an enzyme called reverse transcriptase that HIV needs to convert its genetic material into a form your cells can read. Without this enzyme working properly, the virus can't integrate into your cells.

This is considered a moderately strong HIV regimen. It's effective for most people with HIV, but it may not be the best choice if you have a very high viral load or certain types of drug resistance.

How Should I Take Emtricitabine-Rilpivirine-and-Tenofovir-Alafenamide?

Take this medication exactly as your doctor prescribes, typically one tablet once daily with food. Taking it with food is important because it helps your body absorb the rilpivirine component properly.

You should take it with a meal, not just a snack. A meal with at least 390 calories works best. This could be breakfast, lunch, or dinner - whatever fits your schedule, but try to take it at the same time each day.

Swallow the tablet whole with water. Don't crush, chew, or split the tablet because this can affect how the medicine is released in your body. If you have trouble swallowing pills, talk to your doctor about your options.

Try to establish a routine by taking it at the same time every day. This helps maintain steady levels of the medicine in your bloodstream and makes it easier to remember your dose.

How Long Should I Take Emtricitabine-Rilpivirine-and-Tenofovir-Alafenamide For?

You'll need to take this medication for as long as your doctor recommends, which is typically for life. HIV treatment is a long-term commitment, and stopping the medication can allow the virus to multiply again and potentially develop resistance.

Your doctor will monitor your progress through regular blood tests that check your viral load and CD4 count. These tests help determine how well the medication is working and whether you need to continue with the same treatment.

Never stop taking this medication without talking to your doctor first, even if you feel completely well. HIV can be present in your body without causing symptoms, and stopping treatment suddenly can lead to the virus bouncing back stronger than before.

If you're experiencing side effects or having trouble with the medication, discuss this with your healthcare provider. They may be able to adjust your treatment or help you manage any issues you're experiencing.

What Are the Side Effects of Emtricitabine-Rilpivirine-and-Tenofovir-Alafenamide?

Like all medications, this combination can cause side effects, though not everyone experiences them. Most side effects are mild and tend to improve as your body adjusts to the medication over the first few weeks.

Here are the most common side effects you might experience as your body gets used to the medication:

• Headache
• Trouble sleeping or unusual dreams
• Dizziness
• Nausea
• Fatigue
• Diarrhea
• Skin rash

These common side effects usually become less bothersome after the first month of treatment. If they persist or become troublesome, your doctor can suggest ways to manage them.

Some people may experience less common but more serious side effects that require medical attention. While these don't happen to most people, it's important to be aware of them:

• Severe depression or mood changes
• Kidney problems (changes in urination, swelling)
• Bone problems (unusual bone pain or fractures)
• Liver problems (yellowing of skin or eyes, dark urine)
• Lactic acidosis (unusual fatigue, stomach pain, trouble breathing)
• Severe skin reactions

Contact your doctor right away if you experience any of these more serious side effects. Early intervention can help prevent complications and ensure your treatment stays on track.

Who Should Not Take Emtricitabine-Rilpivirine-and-Tenofovir-Alafenamide?

This medication isn't right for everyone. Your doctor will carefully review your medical history and current health status before prescribing it to make sure it's safe for you.

You should not take this medication if you have severe kidney disease or are on dialysis. The components can affect kidney function, so people with significant kidney problems need different treatment options.

People with severe liver disease, including hepatitis B, may not be good candidates for this medication. If you have hepatitis B, stopping this medication suddenly can cause your hepatitis to get worse, so special monitoring is needed.

This medication may not be the best choice if you have a very high viral load (over 100,000 copies per milliliter) or if you've developed resistance to any of the three components. Your doctor will run tests to check for resistance before prescribing it.

Pregnant women should discuss other options with their doctor, as this particular combination isn't typically the first choice during pregnancy. There are other HIV medications that have more pregnancy safety data available.

Emtricitabine-Rilpivirine-and-Tenofovir-Alafenamide Brand Name

The brand name for this combination medication is Odefsey. It's manufactured by Gilead Sciences and was approved by the FDA in 2016 for the treatment of HIV-1 infection.

Odefsey is available as a single tablet that contains 200 mg of emtricitabine, 25 mg of rilpivirine, and 25 mg of tenofovir alafenamide. This specific combination and dosing isn't available in generic form yet.

When talking to your doctor or pharmacist, you can refer to it by either the brand name Odefsey or the full generic name. Both terms refer to the same medication.

Emtricitabine-Rilpivirine-and-Tenofovir-Alafenamide Alternatives

Several other single-tablet HIV regimens are available if this medication isn't right for you. Your doctor can help you find an alternative that better fits your needs and health situation.

Some alternatives include Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide), which is often preferred for people with higher viral loads. Triumeq (dolutegravir, abacavir, and lamivudine) is another option, particularly for people who can't take tenofovir.

Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) is another single-tablet option that works well for many people. Your doctor might also consider older combinations like Atripla or Complera, depending on your specific situation.

The choice between these options depends on factors like your viral load, kidney function, other medications you take, and potential drug interactions. Your doctor will help you weigh the pros and cons of each option.

Is Emtricitabine-Rilpivirine-and-Tenofovir-Alafenamide Better Than Biktarvy?

Both medications are effective HIV treatments, but they have different strengths and may be better suited for different people. Biktarvy is often considered more potent and can be used in people with higher viral loads.

Biktarvy contains an integrase inhibitor (bictegravir), which is a newer class of HIV medicine that tends to work faster and has fewer drug interactions. It also doesn't require food for absorption, making it more convenient for some people.

However, Odefsey might be a better choice for people who have taken HIV medications before and have developed some resistance patterns. It also tends to cause fewer gastrointestinal side effects in some people.

Your doctor will consider your viral load, treatment history, kidney function, other medications, and personal preferences when choosing between these options. There's no universally "better" choice - it depends on your individual situation.